Skip to Main Content

A government probe into pharmaceutical price fixing widened on Thursday as nearly two dozen state attorneys general filed a lawsuit charging six generic drug companies with collusion in setting prices for two drugs.

The lawsuit alleged that between 2013 and 2015 executives from the six companies and their staffs routinely coordinated efforts to fix and maintain prices for doxycycline hyclate, a widely used antibiotic, and glyburide, a diabetes treatment. The companies named were Mylan Pharmaceuticals, Aurobindo, Citron Pharma, Heritage Pharmaceuticals, Mayne Pharma and Teva Pharmaceutical.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!